ERBB2 and breast cancer: Based on the expression of estrogen or progesterone receptors and human epidermal growth factor 2 (ERBB2; previously known as HER2) molecular markers, the breast cancer subtypes can be categorized into three groups: hormone‐receptor positive/ERBB2 negative (70%), ERBB2 positive (15%–20%), and triple negative (15%).2